Login
$CLYM
$9.57 +$0.76 (8.63%) Close

Company Executives

$CLYM Management Team

Dr. Douglas Williams

Independent Chairman of the Board

Age 67
Compensation $98.39K USD
Sex Male

Dr. Susan Altschuller

Chief Financial Officer

Treasurer

Age 44
Compensation -
Sex Female

Ms. Cindy Driscoll

Senior Vice President - Finance

Age 59
Compensation -
Sex Female

Dr. Aoife Brennan

President

Chief Executive Officer

Director

Age 49
Compensation $6.020M USD
Sex Female
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
2.2 years
from year joined
CEO also chairs the board
No
Douglas Williams, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Douglas Williams, Ph.D.
67 2024
2 years
Not stated
Audit Committee
Camp4 Therapeutics Corp. $205,331
Alexander (Bo) Cumbo
55 2025
1 year
Not stated
Audit Committee
Vor Biopharma, Inc. $168,667
Andrew Levin, M.D., Ph.D.
49 Not stated Not stated None stated Vor Biopharma, Inc. $79,123
Aoife Brennan, M.B., Ch.B.
50 2024
2 years
Not stated None stated Xilio Therapeutics, Inc. Paid as CEO
Kimberlee (Kim) Drapkin
58 2025
1 year
Not stated
Audit Committee · Chair Nominating and Corporate Governance Committee
LENZ Therapeutics, Inc., Imugene Limited, Acumen Pharmaceuticals, Inc $170,569
Judith Dunn, Ph.D.
63 2021
5 years
Not stated None stated None stated $89,748
Stephen Thomas, Ph.D.
37 2024
2 years
Not stated None stated None stated $79,123

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support